Review: ABO blood group system - ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes

Immunohematology

Volumn 20, Issue 1, 2004, Pages 3-22

  Yamamoto, Fumiichiro ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP ANTIGEN; BLOOD GROUP B ANTIGEN; DNA; GLYCOSYLTRANSFERASE; OLIGOSACCHARIDE;

AMINO ACID SUBSTITUTION; ANTIGEN ANTIBODY REACTION; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; CARCINOGENESIS; CELL DIFFERENTIATION; DNA DETERMINATION; ERYTHROCYTE; FORENSIC MEDICINE; GENE LOCUS; GENETIC CODE; GENETIC ENGINEERING; GENOTYPE; HUMAN; MOLECULAR GENETICS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SAFETY;

ABO BLOOD-GROUP SYSTEM; ADULT; ALLELES; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; EVOLUTION, MOLECULAR; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE FREQUENCY; GLYCOSYLATION; HUMANS; IMMUNOLOGIC SURVEILLANCE; INFANT, NEWBORN; ISOANTIBODIES; MAMMALS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; N-ACETYLGALACTOSAMINYLTRANSFERASES; OLIGOSACCHARIDES; POLYMORPHISM, GENETIC; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TRISACCHARIDES;

EID: 1442300724     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Yamamoto F, Marken J, Tsuji T, et al. Cloning and characterization of DNA complementary to human UDP-GalNAc: Fuc alpha 1-2Gal alpha 1-3GalNAc transferase (histo-blood group A transferase) mRNA. J Biol Chem 1990;265:1146-51.
2. Mark Brecher, MD, ed. Technical manual. 14th ed. Bethesda, MD: American Association of Blood Banks, 2003.
3. Wallace ME, Gibbs FL, eds. Blood group systems: ABH and Lewis. Arlington, VA: American Association of Blood Banks, 1986.
4. Harmening D, ed. Modern blood banking and transfusion practices. Philadelphia, PA: FA Davis Co, 1999.
5. Watkins WM. In: Glycoproteins. Montreil J, Shachter, H, eds. Amsterdam: Elsevier, 1995;313-90.
6. Watkins WM. The ABO blood group system: historical background. Transfus Med 2001;11:243-65.
7. Watkins WM. Some genetical aspects of the biosynthesis of human blood group substances In: Ciba Foundation Symposium on Biochemistry of Human Genetics (eds. Wolstenholme GEW, O'Connor CM) London: Churchill, 1959.
8. Watkins WM, Morgan WTJ. Possible genetical pathways for the biosynthesis of blood group mucopolysaccharides. Vox Sang 1959;4:97-119.
9. Ceppellini R. Physiological genetics of human blood factors. In: Ciba Foundation Symposium on Biochemistry of Human Genetics (eds. Wolstenholme GEW, O'Connor CM) London: Churchill, 1959.
10. Ginsburg V. Enzymatic basis for blood groups in man. Adv Enzymol Relat Areas Mol Biol 1972;36:131-49.
11. Tilley CA, Crookston MC, Crookston JH, Shindman J, Schachter H. Human blood-group A- and H-specified glycosyltransferase levels in the sera of newborn infants and their mothers. Vox Sang 1978;34:8-13.
12. Yoshida A, Yamaguchi H, Okubo Y. Genetic mechanism of cis-AB inheritance. I. A case associated with unequal chromosomal crossing over. Am J Hum Genet 1980;32:332-8.
13. Yoshida A, Yamaguchi H, Okubo Y. Genetic mechanism of cis-AB inheritance. II. Cases associated with structural mutation of blood group glycosyltransferase. Am J Hum Genet 1980;32:645-50.
14. Treacy M, Stroup M. A Scientific Forum on Blood Grouping Serum Anti-A (Murine Monoclonal Blend) BioClone. Raritan: Ortho Diagnostic Systems, 1987.
15. Greenwell P, Yates AD, Watkins WM. UDP-N-acetyl-D-galactosamine as a donor substrate for the glycosyltransferase encoded by the B gene at the human blood group ABO locus. Carbohyd Res 1986;149:149-170.
16. Whitehead JS, Bella A, Kim YS. An N-acetylgalactosaminyltransferase from human blood group A plasma. I. Purification and agarose binding properties. J Biol Chem 1974;249:442-7.
17. Whitehead JS, Bella S, Kim YS. An N-acetylgalactosaminyltransferase from human blood group A plasma. II. Kinetic and physicochemical properties. J Biol Chem 1974;249:3448-52.
18. Nagai M, Dave V, Kaplan BE, Yoshida A. Human blood group glycosyltransferases. I. Purification of N-acetylgalactosaminyltransferase. J Biol Chem 1978;253:377-9.
19. Nagai M, Dave V, Muensch H, Yoshida A. Human blood group glycosyltransferase. II. Purification of galactosyltransferase. J Biol Chem 1978;253:380-1.
20. Schwyzer M, Hill RL. Porcine A blood group-specific N-acetylgalactosaminyltransferase. I. Purification from porcine submaxillary glands. J Biol Chem 1977;252:2338-45.
21. Schwyzer M, Hill RL. Porcine A blood group-specific N-acetylgalactosaminyltransferase. II. Enzymatic properties. J Biol Chem 1977;252:2346-55.
22. Clausen H, White T, Takio K, et al. Isolation to homogeneity and partial characterization of a histo-blood group A defined Fuc alpha 1-2Gal alpha 1-3-N-acetylgalactosaminyltransferase from human lung tissue. J Biol Chem 1990;265:1139-45.
23. Navaratnam N, Findlay JB, Keen JN, Watkins WM. Purification, properties and partial amino acid sequence of the blood group A-gene-associated alpha-3-N-acetylgalactosaminyltransferase from human gut mucosal tissue. Biochem J 1990;271:93-8.
24. Takeya A, Hosomi O, Ishiura M. Complete purification and characterization of alpha-3-N-acetylgalactosaminyltransferase encoded by the human blood group A gene. J Biochem (Tokyo) 1990;107:360-8.
25. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229-33.
26. Ferguson-Smith MA, Aitken DA, Turleau C, de Grouchy J. Localisation of the human ABO: Np-1: AK-1 linkage group by regional assignment of AK-1 to 9q34. Hum Genet 1976;34:35-43.
27. Yamamoto F, McNeill PD, Hakomori S. Genomic organization of human histo-blood group ABO genes. Glycobiology 1995;5:51-8.
28. Bennett EP, Steffensen R, Clausen H, Weghuis DO, Geurts van Kessel A. Genomic cloning of the human histo-blood group ABO locus. Biochem Biophys Res Comm 1995;211:347.
29. Yamamoto F, McNeill PD, Hakomori S. Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Comm 1992;187:366-74.
30. 3 alleles. Vox Sang 1993;64:116-9.
31. Yamamoto F, McNeill PD, Yamamoto M, Hakomori S, Harris T. Molecular genetic analysis of the ABO blood group system: 3. A(X) and B(A) alleles. Vox Sang 1993;64:171-4.
32. Yamamoto F, McNeill PD, Kominato Y, et al. Molecular genetic analysis of the ABO blood group system: 2. cis-AB alleles. Vox Sang 1993;64:120-3.
33. Yamamoto F, McNeill PD, Yamamoto M, et al. Molecular genetic analysis of the ABO blood group system: 4. Another type of O allele. Vox Sang 1993;64:175-8.
34. Blumenfeld OO. Mutation databases and other online sites as a resource for transfusion medicine: history and attributes. Transfus Med Rev 2002;16:103-14.
35. el allele-specific nucleotide insertion at the blood group ABO locus and its detection using a sequence-specific polymerase chain reaction. Biochem Biophys Res Comm 1995;216:642-7.
36. Olsson ML, Chester MA. Polymorphisms at the ABO locus in subgroup A individuals. Transfusion 1996;36:309-13.
37. Olsson ML, Chester MA. Frequent occurrence of a variant O1 gene at the blood group ABO locus. Vox Sang 1996;70:26-30.
38. el nucleotide insertion. Vox Sang 1996;71:113-7.
39. Olsson ML, Guerreiro JF, Zago MA, Chester MA. Molecular analysis of the O alleles at the blood group ABO locus in populations of different ethnic origin reveals novel crossing-over events and point mutations. Biochem Biophys Res Comm 1997;234:779-82.
40. Olsson ML, Santos SE, Guerreiro JF, Zago MA, Chester MA. Heterogeneity of the O alleles at the blood group ABO locus in Amerindians. Vox Sang 1998;74:46-50.
41. Hansen T, Namork E, Olsson ML, Chester MA, Heier HE. Different genotypes causing indiscernible patterns of A expression on A(el) red blood cells as visualized by scanning immunogold electron microscopy. Vox Sang 1998;75:47-51.
42. x phenotype. Transfus Med 1998;8:231-8.
43. Olsson ML, Irshaid NM, Hosseini-Maaf B, et al. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles. Blood 2001;98:1585-93.
44. Olsson ML, Chester MA. Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies. Transfus Med 2001;11:295-313.
45. Ogasawara K, Bannai M, Saitou N, et al. Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes. Hum Genet 1996;97:777-83.
46. Ogasawara K, Yabe R, Uchikawa M, et al. Molecular genetic analysis of variant phenotypes of the ABO blood group system. Blood 1996;88:2732-7.
47. 2B phenotypes of the ABO blood group. Vox Sang 1998;74:242-7.
48. Ogasawara K, Yabe R, Uchikawa M, et al. Recombination and gene conversion-like events may contribute to ABO gene diversity causing various phenotypes. Immunogenetics 2001;53:190-9.
49. Roubinet F, Kermarrec N, Despiau S, et al. Molecular polymorphism of O alleles in five populations of different ethnic origins. Immunogenetics 2001;53:95-104.
50. Roubinet F, Janvier D, Blancher A. A novel cis-AB allele derived from a B allele through a single point mutation. Transfusion 2002;42:239-46.
51. Seltsam A, Hallensleben M, Eiz-Vesper B, et al. A weak blood group A phenotype caused by a new mutation at the ABO locus. Transfusion 2002;42:294-301.
52. Seltsam A, Hallensleben M, Kollmann A, Burkhart J, Blasczyk R. Systematic analysis of the ABO gene diversity within exons 6 and 7 by PCR screening reveals new ABO alleles. Transfusion 2003;43:428-39.
53. Yu LC, Lee HL, Chan YS, Lin M. The molecular basis for the B(A) allele: an amino acid alteration in the human histo-blood group B alpha-(1,3)-galactosyltransferase increases its intrinsic alpha-(1,3)-N-acetylgalactosaminyltransferase activity. Biochem Biophys Res Comm 1999;262:487-93.
54. Yu LC, Chang CY, Twu YC, Lin M. Human histo-blood group ABO glycosyltransferase genes: different enhancer structures with different transcriptional activities. Biochem Biophys Res Comm 2000;273:459-66.
55. Yu LC, Twu YC, Chou ML, et al. Molecular genetic analysis for the B(3) allele. Blood 2002;100:1490-2.
56. 3 alleles. Transfusion 2003;43:1138-44.
57. Yip SP, Yow CM, Lewis WH. DNA polymorphism at the ABO locus in the Chinese population of Hong Kong. Hum Hered 1995;45:266-71.
58. Yip SP, Choy WL, Chan CW, Choi CH. The absence of a B allele in acquired B blood group phenotype confirmed by a DNA based genotyping method. J Clin Pathol 1996;49:180-1.
59. Yip SP. Single-tube multiplex PCR-SSCP analysis distinguishes 7 common ABO alleles and readily identifies new alleles. Blood 2000;95:1487-92.
60. Yip SP. Sequence variation at the human ABO locus. Ann Hum Genet 2002;66:1-27.
61. Yamamoto F, Hakomori S. Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J Biol Chem 1990;265:19257-62.
62. Yamamoto E. Molecular genetics of the ABO histo-blood group system. Vox Sang 1995;69:1-7.
63. Yamamoto F, McNeill PD. Amino acid residue at codon 268 determines both activity and nucleotide-sugar donor substrate specificity of human histo-blood group A and B transferases: In vitro mutagenesis study. J Biol Chem 1996;271:10515-20.
64. Seto NO, Palcic MM, Hindsgaul O, Bundle DR, Narang SA. Expression of a recombinant human glycosyltransferase from a synthetic gene and its utilization for synthesis of the human blood group B trisaccharide. Eur J Biochem 1995;234:323-8.
65. Seto NO, Palcic MM, Compston CA, et al. Sequential interchange of four amino acids from blood group B to blood group A glycosyltransferase boosts catalytic activity and progressively modifies substrate recognition in human recombinant enzymes. J Biol Chem 1997;272:14133-8.
66. Patenaude SI, Seto NO, Borisova SN, et al. The structural basis for specificity in human ABO(H) blood group biosynthesis. Nat Struct Biol 2002;9:685-90.
67. Marcus SL, Polakowski R, Seto NO, et al. A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase. J Biol Chem 2003;278:12403-5.
68. Kominato Y, McNeill PD, Yamamoto M, et al. Animal histo-blood group ABO genes. Biochem Biophys Res Comm 1992;189:154-64.
69. Moor-Jankowski J, Wiener AS. Blood group antigens in primate animals and their relation to human blood groups. Primates in medicine 1969;3:64-77.
70. Wiener AS, Socha WW, Moor-Jankowski J. Homologous of the human A-B-O blood groups in apes and monkeys. Haematologia 1974;8:195-216.
71. Martinko JM, Vincek V, Klein D, Klein J. Primate ABO glycosyltransferases: evidence for trans-species evolution. Immunogenetics 1993;37:274-8.
72. Kermarrec N, Roubinet F, Apoil PA, Blancher A. Comparison of allele O sequences of the human and non-human primate ABO system. Immunogenetics 1999;49:517-26.
73. Yamamoto F, Yamamoto M. Molecular genetic basis of porcine histo-blood group AO system. Blood 2001;97:3308-10.
74. Yamamoto M, Lin XH, Kominato Y, et al. Murine equivalent of the human histo-blood group ABO gene is a cis-AB gene and encodes a glycosyltransferase with both A and B transferase activity. J Biol Chem 2001;276:13701-8.
75. Cailleau-Thomas A, Le Moullac-Vaidye B, Rocher J, et al. Cloning of a rat gene encoding the histo-blood group A enzyme. Tissue expression of the gene and of the A and B antigens. Eur J Biochem 2002;269:4040-7.
76. Iwamoto S, Kumada M, Kamesaki T, et al. Rat encodes the paralogous gene equivalent of the human histo-blood group ABO gene. Association with antigen expression by overexpression of human ABO transferase. J Biol Chem 2002;277:46463-9.
77. Saitou N, Yamamoto E. Evolution of primate ABO blood group genes and their homologous genes. Mol Biol Evol 1997;14:399-411.
78. Joziasse DH, Shaper JH, Van den Eijnden DH, Van Tunen AJ, Shaper NL. Bovine alpha-1-3-galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA. J Biol Chem 1989;264:14290-7.
79. Larsen RD, Rajan VP, Ruff MM, et al. Isolation of a cDNA encoding a murine UDP-galactose: beta-D-galactosyl-1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer. Proc Natl Acad Sci USA 1989;86:8227-31.
80. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988;263:17755-62.
81. Platt JL, Parker W. Another step towards xenotransplantation. Nat Med 1995;1:1248-50.
82. Joziasse DH, Shaper JH, Van den Eijnden DH, Van. Tunen AJ, Shaper NL. Bovine alpha-l->3 galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA. J Biol Chem 1989;264:14290-7.
83. Larsen RD, Rivera-Marrero CA, Ernst LK, Cummings RD, Lowe JB. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J Biol Chem 1990;265:7055-61.
84. Yamamoto F, McNeill PD, Hakomori S. Identification in human genomic DNA of the sequence homologous but not identical to either the histo-blood group ABH genes or alpha-1-3 galactosyltransferase pseudogene. Biochem Biophys Res Comm 1991;175:986-94.
85. Haslam DB, Baenziger JU. Expression cloning of Forssman glycolipid synthetase: a novel member of the histo-blood group ABO gene family. Proc Natl Acad Sci USA 1996;93:10697-702.
86. Keusch JJ, Manzella SM, Nyame KA, Cummings RD, Baenziger JU. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem 2000;275:25308-14.
87. Xu H, Storch T, Yu M, Elliott SP, Haslam DB. Characterization of the human Forssman synthetase gene. An evolving association between glycolipid synthesis and host-microbial interactions. J Biol Chem 1999;274:29390-8.
88. Mori E, Mori T, Sanai Y, Nagai Y. Radioimmuno-thin-layer chromatographic detection of Forssman antigen in human carcinoma cell lines. Biochem Biophys Res Comm 1982;108:926-32.
89. Szulman AE. Chemistry, distribution, and function of blood group substances. Annu Rev Med 1966;17:307-22.
90. Szulman AE. The ABH antigens in human tissues and secretions during embryonal development. J Histochem Cytochem 1965;13:752-4.
91. Oriol R. ABH and related tissue antigens. Biochem Soc Trans 1987;15:596-9.
92. Orntoft TE. Carbohydrate changes in bladder carcinomas. APMIS Suppl 1992;27:181-7.
93. Mandel U, Clausen H, Vedtofte P, Sorensen H, Dabelsteen E. Sequential expression of carbohydrate antigens with precursor-product relation characterizes cellular maturation in stratified squamous epithelium. J Oral Pathol 1988;17:506-11.
94. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1999;1473:247-66.
95. Mourant AE, Kopec AC, Donaniewska-Sobczar K. Blood groups and diseases. Oxford, UK: Oxford University Press, 1978.
96. Masamune H, Kawasaki H, Abe S, Oyama K, Yamaguchi Y. Molisch positive mucopolysaccharides of gastric cancers as compared with the corresponding components of gastric mucosa. Tohoku J Med 1958;68:81-91.
97. Stellner K, Hakomori S, Warner GS. Enzymic conversion of "H1-glycolipid" to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma. Biochem Biophys Res Comm 1973;55:439-45.
98. a activity in the mucus from human neoplastic colon. Rev Fr Transfus Immuno-Hematol 1980;23:599-611.
99. Orntoft TF, Greenwell P, Clausen H, Watkins WM. Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation. Gut 1991;32:287-93.
100. Lee JS, Ro JY, Sahin AA, et al. Expression of blood-group antigen A - a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991;324:1084-90.
101. Miyake M, Taki T, Hitomi S, Hakomori S. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med 1992;327:14-8.
102. Hakkinen I. A-like blood group antigen in gastric cancer cells of patients in blood groups Q or B. JNCI 1970;44:1183-93.
103. Denk H, Tappeiner G, Davidovits A, Eckerstorfer R, Holzner JH. Carcinoembryonic antigen and blood group substances in carcinomas of the stomach and colon. JNCI 1974;53:933-42.
104. Kapadia A, Feizi T, Jewell D, Keeling J, Slavin G. Immunocytochemical studies of blood group A, H, I, and i antigens in gastric mucosae of infants with normal gastric histology and of patients with gastric carcinoma and chronic benign peptic ulceration. J Clin Pathol 1981;34:320-37.
105. Hattori H, Uemura K, Ogata H, et al. Characterization of glycolipids from the gastric cancer of a patient of p, O, Le(a-b+) blood type: presence of incompatible blood group antigens in tumor tissues. Cancer Res 1987;47:1968-72.
106. Metoki R, Kakudo K, Tsuji Y, et al. Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian cancer. JNCI 1989;81:1151-57.
107. Hattori H, Uemura K, Ishihara H, Ogata H. Glycolipid of human pancreatic cancer; the appearance of neolacto-series (type 2 chain) glycolipid and the presence of incompatible blood group antigen in tumor tissues. Biochim Biophys Acta 1992;1125:21-7.
108. Clausen H, Hakomori S, Graem N, Dabelsteen E. Incompatible A antigen expressed in tumors of blood group O individuals: immunochemical, immunohistologic, and enzymatic characterization. J Immunol 1986;136:326-30.
109. David L, Leitao D, Sobrinho-Simoes M, et al. Biosynthetic basis of incompatible histo-blood group A antigen expression: anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. Cancer Res 1993;53:5494-500.
110. Meldgaard P, Holmes EH, Bennett EP, et al. Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization. Cancer Res 1994;54:2440-7.
111. Meldgaard P, Johnson PH, Langkilde NC, Wolf H, Orntoft TE. Loss of ABH antigen expression in bladder cancer is not caused by loss of heterozygosity of the ABO locus. Int J Cancer 1995;63:341-4.
112. Kominato Y, Tsuchiya T, Hata N, Takizawa H, Yamamoto F. Transcription of human ABO histo-blood group genes is dependent upon binding of transcription factor CBF/NF-Y to minisatellite sequence. J Biol Chem 1997;272:25890-8.
113. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-96.
114. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
115. Kominato Y, Hata Y, Takizawa H, et al. Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. J Biol Chem 1999;274:37240-50.
116. Iwamoto S, Withers DA, Handa K, Hakomori S. Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. Glycoconj J 1999;16:659-66.
117. Cooper NR, Jensen FC, Welsh RM Jr., Oldstone MB. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med 1976;144:970-84.
118. Banapour B, Sernatinger J, Levy JA. The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology 1986;152:268-71.
119. Hoshino H, Tanaka H, Miwa M, Okada H. Human T-cell leukaemia virus is not lysed by human serum. Nature 1984;310:324-5.
120. Takeuchi Y, Cosset FL, Lachmann PJ, et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994;68:8001-7.
121. Rother RP, Fodor WL, Springhorn JP, et al. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med 1995;182:1345-55.
122. Takeuchi Y, Porter CD, Strahan KM, et al. Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. Nature 1996;379:85-8.
123. Arendrup M, Hansen JE, Clausen H, et al. Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors. AIDS 1991;5:441-4.
124. Preece AF, Strahan KM, Devitt J, Yamamoto F, Gustafsson K. Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement. Blood 2002;99:2477-82.
125. Daniels G. Human blood groups. Oxford: Blackwell Science, 1995.
126. Schenkel-Brunner H. Human blood groups. New York: Springer-Verlag, 2000;54-150.